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Abstract: Nano-sized graphene and graphene oxide (GO) are
promising for biomedical applications, such as drug delivery
and photothermal therapy of cancer. It is observed in this
work that the ultrafast reduction of GO nanoparticles (GONs)
with a femtosecond laser beam creates extensive microbub-
bling. To understand the surface chemistry of GONs on the
microbubble formation, the GONs were reduced to remove
most of the oxygen-containing groups to get reduced GONs
(rGONs). Microbubbling was not observed when the rGONs
were irradiated by the laser. The instant collapse of the
microbubbles may produce microcavitation effect that brings
about localized mechanical damage. To understand the
potential applications of this phenomenon, cancer cells
labeled with GONs or rGONs were irradiated with the laser.
Interestingly, the microbubbling effect greatly facilitated the
destruction of cancer cells. When microbubbles were produced,
the effective laser power was reduced to less than half of what
is needed when microbubbling is absent. This finding will con-
tribute to the safe application of femtosecond laser in the medi-
cal area by taking advantage of the ultrafast reduction of GONs.
It may also find other important applications that need highly
localized microcavitation effects. VC 2013 Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 102A: 2181–2188, 2014.
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INTRODUCTION
Graphene has excellent mechanical and physical proper-
ties.1,2 Besides the general interest in electronic applications
of graphene, graphene and its derivatives are promising
materials for biomedical applications.3 In this regard, gra-
phene oxide (GO) is a subject of particular interest due to
its richness in functional groups. This facilitates its surface
functionalization for applications such as drug delivery,4,5
biosensing, and bioimaging.6–10 Recently, there has been a
growing interest in using graphene-related nanomaterials for
photothermal therapy of cancer and other diseases.3,8,11–13
Due to its high light absorption, reduced GO has been of
particular interest when a continuous wave laser is
used.14,15 Temperature increase in the nanoparticles caused
by laser irradiation is the mechanism of cell therapy.
The production of graphene largely relies on the reduc-
tion of its oxidized form (i.e., GO) in water. The general
methods to reduce GO include chemical16,17 and physical
(heat and light exposure) approaches.18,19 With the physical
methods, the oxygen-containing groups such as carboxylic
and hydroxyl groups on GO can be removed with the release
of gases such as CO2 and H2O. As a physical tool, laser has
been used to reduce GO, leading to precise micromachining
of electronic devices.18 Ultrafast laser is an effective tool for
nanofabrication due to the high pulse energy.20,21 Under the
irradiation of such a laser, the temperature of graphene can
be increased to a few thousand degrees in microseconds.8,22
The ultrafast temperature increase can in principle reduce
GO simultaneously. This in turn will lead to simultaneous
release of gases, promoting instant formation and collapse
of microbubbles in a solution. The high pressure caused by
the collapse of microbubbles (microcavitation) has many
important applications such as micro/nanovoids formation
for fabrication of photonic crystals and cancer cell therapy.
In our recent article, microbubbling from graphene oxide
nanoparticles (GONs) under the irradiation of a femtosecond
laser beam has been observed and the collapse of micro-
bubbles was accompanied with the damage of cancer cells.8
However, the mechanism of microbubbling and the contri-
bution of microcavitation to cancer cell therapy were not
understood. A good understanding of these is essential to
the design of an energy efﬁcient photothermal treatment.
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In this work, the microbubble formation enhanced by
GONs under the irradiation of a femtosecond laser beam
and its effects on in vitro cancer cell damage were exam-
ined. GONs were prepared using a modiﬁed Hummers
method.23 Reduced GONs (rGONs) were obtained by ultra-
violet (UV) irradiating GONs to remove most of the oxygen-
containing groups from the surface of the nanoparticles. It
is anticipated that microbubbling can be suppressed if most
of the functional groups are removed. Hence, the contribu-
tion of microcavitation to cell therapy can be elucidated by
comparing the efﬁciency of GONs and rGONs. Interestingly,
it was observed that under the irradiation of a femtosecond
laser beam, extensive microbubbling could be produced
from GONs in aqueous medium. The production of micro-
bubbles and their collapse occurred in microseconds. Micro-
bubbling was not observed in the case of rGONs. The
microcavitation induced by the ultrafast reduction of GONs
lowered the effective laser power for therapy from 9 mW to
4 mW.
MATERIALS AND METHODS
Materials
Graphite, Transferrin, fetal bovine serium, Roswell Park
Memorial Institute medium-1640 medium containing L-glu-
tamine and sodium bicarbonate, calcein acetoxymethyl
(AM), ethidium bromide, and phosphate-buffered saline
(PBS) tablets were obtained from Sigma. Amine-
functionalized polyethylene glycol (PEG-NH2, MW 5000)
was obtained from Nanocs. All the chemicals were used as
received.
Preparation and characterization of GONs
GO was obtained by exfoliating graphite following a
reported method with modiﬁcations.23 The GO solution was
then sonicated for 30 min to yield a mixture of particles
and sheets. GONs were harvested by centrifuging the solu-
tion of the mixture at 25,000 rcf for 30 min to remove the
GO sheets.
Reduction of GONs
To obtain rGONs, 40 mL of GONs at a concentration of 50
mg/mL was contained in a sample weighting plate and sub-
jected to UVB irradiation for 24 h. After irradiation, the ﬁnal
volume was adjusted to 40 mL. The UV–visible absorption
of the particle solutions was measured.
X-Ray photoelectron spectroscopy
X-ray photoelectron spectroscopy was used to characterize
the surface functional groups of GONs after light irradiation.
A monochromatized X-ray source (He I, hm 521.2 eV) was
used.
Surface functionalization of GONs and rGONs
To coat GONs and rGONs with transferrin molecules, ali-
quots of concentrated transferrin was added into 10 mL of
GONs (50 mg/mL) or rGONs (50 mg/mL) dispersion in water.
The transferrin-coated nanoparticles were centrifuged to
remove excess transferrin molecules and dispersed in cell
culture medium RMPI for in vitro therapy. The concentration
of transferrin molecules on nanoparticles was calculated
from the transferrin concentrations in the initial solution
and in the supernatant after conjugation, as measured by a
UV–visible spectrometer. By tuning the concentration of
transferrin, the ratio of transferrin to nanoparticles was
achieved the same (0.25:1 by weight) for GONs and rGONs.
To stabilize the nanoparticles in culture buffer, PEG-NH2
(molecular weight 5000) was also coated on the nanopar-
ticles after protein coating. The excessive PEG-NH2 was
removed by centrifuging the nanoparticles and redisperse
them in PBS buffer.
Microbubbling testing on glass cover slips
An Olympus Fluoview inverted scanning microscope
(FV300) was used for microbubbling examination on cover
slips and for treatment of cancer cells. The laser is a femo-
tosecond Ti:sapphire laser (MaiTai, Spectra Physics) with a
repetition rate of 80 MHz, a pulse width of 100 fs and a
tunable wavelength from 690 nm to 1040 nm. The wave-
length was ﬁxed at 800 nm. A water immersion objective
lens (603, NA: 1.2) was used. A small volume of dilute dis-
persion of GONs or rGONs was deposited on a cover slip.
The sample was dried naturally at room temperature.
Before imaging, a small drop of water was put on each
cover slip to cover the nanoparticles.
In vitro therapy
To evaluate the microcavitation effect on cancer cell therapy,
a gastric cancer cell line (AGS) was used as a model. The
cancer cells were labeled with either transferrin-coated
GONs or transferrin-coated rGONs. Cells were incubated
with nanoparticles for 6 h in 24-well plates with cover slips
as bottom of the wells. When cells had been incubated with
the nanoparticles for 5.5 h, 10 mL of concentrated calcein
AM was added into each well. The concentration of calcein
AM in the cell culture medium was 10 mM. After 30 min,
the cells were washed twice with PBS and fresh medium
(0.5 mL) was then added into each well. The incident power
was measured at the focus point. After treatment, the laser
power was reduced to 3 mW to avoid further cell damage
during imaging.
RESULTS AND DISCUSSION
GO prepared in this work is a mixture of micrometer-sized
large sheets and small GONs (Supporting Information Fig.
S1; the fraction of GONs by weight is about 25%). GONs
were harvested with a centrifuge. An AFM image of the
GONs is shown in Figure 1(a). Dynamic laser scattering indi-
cates that the size of the nanoparticles is peaked at 28 nm
[Fig. 1(b)]. A three-dimensional (3D) AFM measurement
shows that the thickness of GONs ranges from a few nano-
meters to 12.5 nm. This indicates the nanoparticles consist
of multilayers of graphene. To get rGONs, a dilute dispersion
of GONs in water was irradiated with a UV light (UVB) for
24 h. Further irradiation led to aggregation of the nanopar-
ticles, meaning that most of the hydrophilic groups on the
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surface of the nanoparticles were removed, which is also
proven by the surface characterization with XPS.
The microbubbling of water, in the presence of GONs
and rGONs when excited by a femtosecond laser beam, was
examined on glass cover slips. This experiment and those
for cell therapy were performed on an Olympus Fluoview-
300. The laser is from Spectra Physics, with a repetition
rate of 80 MHz and a pulse width of 100 fs. The wavelength
was ﬁxed at 800 nm. For GONs, it was observed that exten-
sive microbubbling occurred when the laser power was
above 4 mW. This was not observed in the case of rGONs,
due to the presence of minimal oxygen-containing groups
on these nanoparticles. Nano-sized graphene and GO have
demonstrated strong two-photon luminescence (TPL), which
enables their imaging both in vitro and in vivo.8,24–26 Figure
2 gives both the TPL images and transmission images of
GONs and rGONSs after being raster scanned at 8 mW. It
was also observed that the number of microbubbles
reduced quickly, with most of them disappeared after three
scans, indicating the fast reduction of GONs. The scanning
area was ﬁxed at 80 mm 3 80 mm and each scan took one
second. On the basis of these, it is estimated that the expo-
sure time of one nanoparticle to laser in one raster scan is
about 20 ms.27 This means that the reduction of GONs takes
place quickly within microseconds. Such a fast reduction is
attributable to the high peak power of a laser pulse. For a
pulsed laser with a repetition rate of 80 MHz and a pulse
width of 80 fs, the pulse peak power is 1.25 kW at an aver-
age laser power of 8 mW. In addition, the instant high tem-
perature increase also contributes to the ultrafast thermal
reduction of GONs. XPS characterization indicates that about
half of the oxygen-containing groups [as compared to Fig.
1(d)] was removed after three scans at this laser power
[Fig. 1(f)].
To illustrate the potential applications of the ultrafast
reduction of GO, the effects of microbubbling on cancer cell
therapy was performed in vitro. A gastric cancer cell line
(AGS) was used as a model. To facilitate cellular uptake of
the nanoparticles and to stabilize the nanoparticles in cell
culture buffer, both the GONs and rGONs were coated with
transferrin molecules and PEG molecules physically. The
selection of a physical other than a covalent conjugation
method is based on the consideration that GONs and rGONs
have different contents of functional groups. This will make
it hard to functionalize them with a same amount of protein
molecules. Graphene has an excellent afﬁnity to protein and
PEG. Physically coating is generally used for the functionali-
zation of rGONs.28 Transferrin has been proven to be an
effective ligand for targeting various cancer cells due to the
upregulation of transferrin receptors on cancer cells.27,29–32
The number of transferrin molecules adsorbed on GONs and
rGONs were kept the same by adjusting the concentration
of transferrin. Each milligram of GONs or rGONs was coated
with 0.25 mg of transferrin. UV–visible absorption indicates
the coating of transferrin on the nanoparticles (Fig. 3).
TPL imaging indicates that the cellular uptake of GONs
and rGONs is similar (Fig. 4). When the particles are not
coated with transferrin, signiﬁcantly reduced cellular
FIGURE 1. Characterization of GONs and rGONs. (a) AFM images of as-synthesized GONs, (b) particle size distribution from dynamic light scat-
tering, (c) a 3D images of GONs, XPS spectra of (d) GONs, (e) rGONs, and (f) GONs after being scanned with a femtosecond laser beam three
times at 8 mW. The results in (d) and (e) show that most of the oxygen-containing groups particularly the hydroxyl groups (C–OH) and epoxy
groups (C–O–C) have been removed in the rGONs.
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targeting of both GONs and rGONs was observed. The con-
centrations of the particles were ﬁxed at 50 lg/mL. No tox-
icity to cells was observed for both types of nanoparticles
at this concentration. Good in vitro and in vivo biocompati-
bility of GO and reduced GO has also been reported.8,15,33
For in vitro work, the nanoparticles at concentrations up to
more than 200 mg/mL did not show obvious toxicity to
cells. For in vivo work, GO nanosheets at a dose of 20 mg/
kg did not show any toxicity to mice.33 In this work, the
cells were incubated with the nanoparticles for 6 h before
imaging was taken. Therefore, the images show that most of
the nanoparticles were localized on the membrane of cells.
For chemotherapy, delivery of drug carrier nanoparticles
into cells is necessary for efﬁcient treatment. In contrast,
photothermal treatment aims to destroy cells physically,
which makes it not necessary to deliver nanoparticles into
cells. It has been demonstrated that more efﬁcient photo-
thermal treatment can be achieved when gold nanorods
were attached to cell membrane since cell membrane is
more liable to thermal shock.34
Figure 5 gives the images of in vitro cell therapy using
the femtosecond laser. Calcein AM was used to examine the
effects of laser irradiation on cell viability. Calcein AM is a
nonﬂuorescent hydrophobic dye that can enter live and
intact cells easily. A live cell emits green ﬂuorescence and
the color fades when the viability of a cell is compromised.
It was observed that when cells were not labeled with par-
ticles (row 1, Fig. 5), a high laser power had to be used to
bring about therapeutic effects. After cells were raster
scanned 45 times at a laser power of 25 mW, the viability
of a fraction of cells in the irradiated area diminished, which
was accompanied with extensive membrane blebbing (the
left two images in row 1). Membrane blebbing often occurs
when a cell is under stresses such as the presence of toxins
and introduction of a thermal shock.27,34 When the laser
power was increased to 30 mW, instant damage to cell
membrane was observed (the right two images in row 1).
Interestingly, when cells were labeled with GONs, a few
scans at a power above 4 mW were enough for cell therapy
(row 2, Fig. 5). The ﬂuorescence from calcein AM in some
cells disappeared during the raster scanning, indicating the
instant damage of cells by the nanoparticles. When cells
were labeled with rGONs, signiﬁcant reduction in cell viabil-
ity was achieved when the cells were scanned 15 times at a
laser power of 9 mW, while only a small fraction of cells
were dead after the cells were scanned a hundred times at
8 mW. This is in sharp contrast to the cells labeled with
GONs. In that case, a few raster scans are enough to induce
cell death at this laser power. Considering the similar cellu-
lar uptakes of the nanoparticles, the difference should be
FIGURE 2. Examination of microbubble formation from GONs and rGONs deposited on cover slips. The laser power was fixed at 8 mW. The
scale bars represent 10 mm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
2184 LI ET AL. PHOTOTHERMAL CANCER CELL THERAPY
FIGURE 3. (a) UV–visible absorption spectra of GONs, GON-Trf, rGONs, and rGO-Trf and free transferrin (Trf) molecules in PBS buffer, (b) is
enlarged from (a) to show the absorption peak of transferrin at 280 nm. Due to the low concentration of Trf, the characteristic absorption peak
at 280 nm is not obvious on the Trf-coated GONs (GONs-Trf) and Trf-coated rGONs(rGONs-Trf). However, the presence of Trf is evidenced by
the absorbance change in the wavelength between 200 nm and 250 nm, (c) an optical image of the GONs and rGONs dispersed in water (left:
GONs; right: rGONs), and (d) absorbance ratio of rGONs to GONs at different wavelengths. With increase in wavelength, the ratio increases and
approaches a constant. The absorbance of rGONs is a magnitude higher than that of GONs at a wavelength above 550 nm (ratio is larger than
10). The concentration of both GONs and rGONs is 50 mg/mL. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 4. In vitro two-photon luminescence (TPL) imaging of (a) transferrin-coated GONs (GONs-Trf), (b) transferrin-coated rGONs (rGONs-Trf),
and not functionalized (c) GONs and (d) rGONs. Gastric (AGS) cancer cells were used. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
caused by the microbubble formation. When cells were
labeled with GONs, the collapse of microbubbles can create
a high mechanical force which compromises the cell mem-
brane instantly. Unlike the case of GONs, microbubbling was
not observed for cells labeled with rGONs. Instead, extensive
cell membrane blebbing was observed (the right most
image of row 3), which is similar to what happened to cells
without nanoparticle labeling (25 mW, 45 scans). This
means that the in these two cases, the cell death should be
caused by the photothermal effects similarly. The numbers
of scan need to bring about cell death are summarized in
Figure 6. When cells were not labeled with particles, cell
death was not observed after they were raster scanned 200
times. The different effects of GONs and rGONs on photo-
thermal therapy were also demonstrated for noncancerous
skin cells (HFF; Supporting Information Fig. S2). Due to the
lower uptake of the nanoparticles by HFF cells, a power of
11 mW (ﬁve raster scans) was observed to induce thera-
peutic effects on cells labeled with GONs. In contrast, no
cell damage were observed when the laser power was
increased to 15 mW (50 raster scans) when the cells were
labeled with rGONs.
Due to its high light absorption, reduced GO has been a
preferable choice for photothermal treatment when continu-
ous wave lasers were used.14,35,36 As is shown by the UV-
visible absorption spectra [Fig. 3(a)], the rGONs have much
higher light absorption than GONs. This is also indicated by
the optical images of the dispersions of the particles in
water [Fig. 3(c)]. At a wavelength of 800 nm, which was
used for cancer cell treatment in this work, the absorbance
of rGONs is more than twenty times of that of GONs [Fig.
3(d)]. Considering the sizes of the nanoparticles are much
FIGURE 5. Laser therapy of cells without nanoparticle labeling (row 1), labeled with GONs (row 2), and (c) rGONs (row 3). To avoid further dam-
age to cells, the laser power was reduced to 3 mW for imaging. The GONs and rGONs are functionalized with transferrin to enhance their cellu-
lar uptake. All the images were taken at a same photomultiplier (PMT) level (700). The scale bars represent 10 mm. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 6. Numbers of laser raster scan needed to bring about cell
death.
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smaller than the wavelength of the incident laser, the energy
loss due to scattering is negligible. Therefore, the energy
absorbed by rGONs is more than 20 times of that by GONs,
which means that the temperature rise of rGONs should be
higher than GONs. If only temperature increase contributes
to cell death, rGONs should be more effective than
GONs. The fact that GONs are more effective than rGONs
indicates the microcavitation effect contributes more to cell
therapy.
CONCLUSIONS
In summary, it is demonstrated that the ultrafast reduction
of GO can promote microbubbling of water that helps to
destruct cancer cells. The in vitro testing in this study
showed that the microbubbles were produced only on cells
labeled with GONs and the microbubbles collapsed instantly,
so hopefully they may not disturb the local blood ﬂow in an
in vivo situation. More importantly, near infrared pulsed
laser is the light source for multiphoton microscopy, which
has been used as a tool for deep tissue imaging and cell
therapy.37,38 With the imaging capability of multi-photon
microscopy, the laser exposure can be precisely controlled
on the malignant cells. Low and high intensity lasers can be
used to image/identify and treat malignant cells, respec-
tively. In this way, hazard to adjacent normal cells and blood
vessels can be prevented. The observations in this work
indicate that by combining multiphoton microscopy (pow-
ered by a femtosecond laser) and GONs, low energy and in
vivo laser microsurgery of cancer is achievable. More
detailed and in-depth work including long term monitoring
of the photothermal effects on cells after treatment and in
vivo therapy are interesting for further research. The micro-
cavitation effect caused by the instant physical–chemical
changes in GO can be hopefully used for the applications
beyond cancer treatment such as voids creation for fabrica-
tion of photonic crystals.
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